33
Participants
Start Date
September 30, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
Levetiracetam
"Intravenous 100 mg/mL, twice a day, maximum of 4 days~Subjects on oral levetiracetam at study entry receive the same intravenous (IV) dosage (mg-for-mg) to their oral dose.~Dosage for subjects not on levetiracetam at study entry was based on weight: if \<50 kg, the dose was 20 mg/kg/day (10 mg/kg/day twice daily); if weight ≥ 50 kg, the dose of levetiracetam intravenous (LEV IV) was 1000 mg/day (500 mg twice daily)."
La Jolla
Boston
Chesterfield
Buffalo
Philadelphia
Nashville
Fort Worth
Richmond
Milwaukee
Brussels
Ghent
Leuven
Amiens
Lille
Paris
Heidelberg
Kehl
Torreón
Puebla City
Aguascalientes
Guadalajara
Mexico City
Puebla City
Ankara
Izmir
Lead Sponsor
UCB Pharma
INDUSTRY